Anti-inflammatory and anti-vaginitis food composition and pharmaceutical composition containing Lactobacillus
US9011839B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Apr 29, 2011 |
| Grant date | Apr 21, 2015 |
| Priority date | — |
| Expiry date | Feb 7, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2400/181
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An anti-inflammatory and anti-vaginitis food composition and/or pharmaceutical composition includes Lactobacillus salivarius subsp. salicinius AP-32 (CCTCC stock No. M2011127), Lactobacillus reuteri TE-33 (CCTCC stock No. M2011126), Lactobacillus acidophilus F-1 (CCTCC stock No. M2011124), Lactobacillus rhamnosus CT-53 (CCTCC stock No. M2011129) or combinations thereof. The present invention may inhibit TNF-α secretion and promote IL-10 secretion of dendritic cells and therefore inhibit inflammation, particularly inflammation of vagina mucosa cells. The present invention may be presented as oral probiotics and direct-use vagina probiotics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.